Navigation Links
T2 and collaborators announce discovery of novel clot structure biology enabled by T2HemoStat
Date:1/9/2014

Lexington, MA, January 9, 2014 T2 Biosystems, a company developing direct detection products enabling superior diagnostics, announced that scientists from the University of Pennsylvania and T2 Biosystems have published a paper in Blood describing novel clot structure biology detected while testing T2 Bio's T2HemoStat. T2HemoStat is an innovative diagnostic tool for assessing blood clotting, platelet function, fibrinolytic activity and hematocrit measurements from a fingerstick blood sample in about 15 minutes. T2HemoStat uniquely detects millions of data points during a blood coagulation cascade. Researchers at the University of Pennsylvania, utilizing T2HemoStat, detected a signature of a novel clot structure, never before described in scientific literature. This clot structure involves a conformational change in red blood cell structure, termed polyhedrocytes. The presence of these structures could make stroke and heart attack victims less responsive to medications.

Blood clots are made up of fibrin, platelets and erythrocytes. Before now, little was known about the internal structure of contracted clots or the role that erythrocytes play in the contraction process. T2HemoStat is the first diagnostic method to enable the detection of this unique clot structure where erythrocytes are closely packed as polyhedra (polyhedrocytes) to form a seemingly impermeable barrier. This barrier means that these clot structures may be less susceptible to certain medications, called fibrinolytics, used to break up blood clots in the treatment of heart attacks and strokes.

"Physicians treating the millions of patients at risk for thrombosis and bleeding, including after surgery or trauma, are in need of a more convenient method to provide up to the minute results of key hemostatic parameters," commented co-author Douglas B. Cines, MD, Professor of Pathology and Laboratory Medicine and Director of the Special Coagulation Laboratory, Perelman School of Medicin
'/>"/>

Contact: Kari Watson
kwatson@macbiocom.com
781-235-3606
MacDougall Biomedical Communications, Inc.
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. WHOI researchers, collaborators receive $1.4 million grant to study life in oceans greatest depths
2. Biogen Idec and Sangamo BioSciences Announce Global Collaboration to Develop Treatments for Hemoglobinopathies
3. MARC travel awards announced for the APS 2014 Professional Skills Training Course
4. CROS NT Ltd Announces Acquisition of MDSL International Ltd.
5. FacialNetwork.com Announces Beta Release Of "NameTag" The First Real-Time Facial Recognition App For Google Glass
6. HGH Supplements Information Website HGH.us.com Announces New Discounts on Sytropin and Genf20 Plus
7. BBSRC announces £10M of funding for advanced scientific equipment
8. Life Sciences Discovery Fund announces R&D grants
9. Genetics Society of America announces recipients of spring 2014 DeLill Nasser Award
10. CROS NT Ltd Announces Appointment of Andrew MacGarvey as CEO
11. Biophysical Society announces speakers for Future of Biophysics Burroughs Wellcome Fund Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... September 2, 2014 In a new study that ... the Florida campus of The Scripps Research Institute (TSRI) ... into unique manufacturing sites for molecules that can treat ... cell as a reaction vessel and a disease-causing defect ... diseased cell," said TSRI Professor Matthew Disney.,"Because the treatment ...
(Date:9/2/2014)... sequence their genetic information. How is it possible ... parts of the body are so different? While every ... additional regulatory layer exists that determines which of the ... modifications of genome-bound histone proteins or the DNA itself ... top of the genetic information and is thus called ...
(Date:9/2/2014)... issue of The FASEB Journal , ... the leading cause of blindness in adults, diabetic ... advance involves quantifying the early molecular changes caused ... Using new probes developed by scientists, they were ... diabetic retinopathy. , "My goal is to establish ...
Breaking Biology News(10 mins):Scripps Florida scientists make diseased cells synthesize their own drug 2Throwing a loop to silence gene expression 2Molecular probes permit doctors to detect diabetic retinopathy before vision fails 2
... and other insects to flap their wings, jump and ... in an article in the journal ACS Macro ... a protein called resilin in nanosprings, biorubbers, biosensors and ... scientists discovered resilin a half-century ago in the wing ...
... deep underground could at the same be used to release ... thus offsetting some of the environmental impact of burning fossil ... peer-reviewed International Journal of Oil, Gas and Coal Technology ... previously untapped fossil fuel reserves has been in the headlines ...
... don,t expect to catch the flute-like song of a Veery ... hoots, and is singing much less to ensure that it ... by Kenneth Schmidt of Texas Tech University and Kara Loeb ... journal Behavioral Ecology and Sociobiology , provides insights into ...
Cached Biology News:Sequestration and fuel reserves 2Veeries very quiet when owls are about 2
(Date:9/2/2014)... NEW YORK , September 2, 2014 ... Market Study on Membrane Technology in Pharmaceutical, Biopharma and ... Witness Highest Growth by 2019" the global membrane technology market for ... 7,029.9 million in 2014 and is expected to grow ... to reach an estimated value of USD 10,886.0 million ...
(Date:9/2/2014)... 2014 Myriant Corporation, a global ... a distribution agreement with Azelis Group, a specialty ... bio-succinic acid in the Nordics, Benelux, France, Iberia, ... in the industrial and base chemicals markets. , ... a far-reaching chemical portfolio with extensive distribution networks ...
(Date:9/2/2014)...  Xencor, Inc. (NASDAQ: XNCR ), ... for the treatment of autoimmune diseases, asthma and ... of Debra Zack , M.D., Ph.D., vice ... Lloyd Rowland , senior vice president, chief compliance ... expertise in biologics clinical development and medical affairs ...
(Date:9/2/2014)... , Sept. 2, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" ... million. The orders consist of three large odour control systems ... . "These orders are consistent with the market ... Peter Bruijns , President and CEO. "After a difficult period ... are now beginning to see sales growth. Our lower cost ...
Breaking Biology Technology:Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 3Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 4Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 5Myriant and Azelis Sign European Distribution Agreement for Bio-Succinic Acid 2Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 2Xencor Appoints Debra Zack, M.D., Ph.D., Vice President, Clinical Development and Lloyd Rowland, Senior Vice President, Chief Compliance Officer and General Counsel 3
... in third quarter 2008; up 40% year-to-date , ... goodwill impairment charge , , ... Inc. (Nasdaq: ENCO ) , a full service ... countries for many of the world,s leading pharmaceutical and ...
... this years, most unique must-have gift , ... New York, NY(PRWEB) November ... from the customers, DNA, launch DNA Mini Portraits™, a more affordable line ... DNA Minis are the most personal and unique gifting solution for this ...
... Zounds Hearing, a unique manufacturing,and retail company ... point and professional service, announces the introduction of,assistive ... all who are hard of,hearing. The various devices ... Hearing,Centers retail locations effective November 24, 2008. ...
Cached Biology Technology:Encorium Reports Third Quarter 2008 Financial Results 2Encorium Reports Third Quarter 2008 Financial Results 3Encorium Reports Third Quarter 2008 Financial Results 4Encorium Reports Third Quarter 2008 Financial Results 5Encorium Reports Third Quarter 2008 Financial Results 6Encorium Reports Third Quarter 2008 Financial Results 7Encorium Reports Third Quarter 2008 Financial Results 8Encorium Reports Third Quarter 2008 Financial Results 9DNA 11, Creators of DNA Art, Introduces a More Affordable Line of Custom Portraits for this Year's Gift Giving Season 2Zounds Offers the Gift of Hearing This Holiday Season With a Range of New Products 2
... is a 10.0 kb Autographa californica (AcNPV) ... the AcNPV polyhedrin promoter and two AcNPV ... is a Sma I cloning site, followed ... this,an inverted polyhedrin promoter has been inserted ...
... a mixture of Strep•Tag® II fusion proteins ... markers provide precise size references for proteins ... blue. Because each of the proteins contains ... also be detected by the Strep•Tag II ...
... The UltraRocker rocking platform, 120 V, is ... overnight incubation of liquid cultures, staining and destaining ... rocker features variable speed control (8-40 rpm) and ... (10 lb). The rocker features two 29 x ...
...
Biology Products: